新“医改”背景下我国临床药学的发展策略探讨  

Development Strategy of Clinical Pharmacy under the Condition of New Medical Reform in China

作　　者：冒小璟[1] 李歆[1] 徐群为[1] 朱东亚[1] 

机构地区：[1]南京医科大学药学院,南京市210029

出　　处：《中国药房》2010年第18期1633-1636,共4页China Pharmacy

基　　金：2009年江苏省高等教育教学改革立项研究课题(NJ22229053)

摘　　要：目的:探索当前"医改"政策背景下我国临床药学的发展策略。方法:分析我国临床药学的发展现状及存在的主要障碍,探讨"医改"政策给我国临床药学发展带来的机遇。结果:"医改"方案中的公立医院补偿机制改革、国家基本药物制度、"医保"制度、药事服务费制度以及基层医疗与公共卫生服务体系的建设等政策为临床药学的发展提供了机遇。结论:设计推动我国临床药学的发展策略应紧密结合"医改"方案,完善临床药学的相关政策、法律与法规,并优化临床药学人才培养机制、探索临床药师深入基层开展工作的内容与方法。OBJECTIVE： To study the development strategy of clinical pharmacy under the condition of New Medical Reform in China. METHODS： The status quo and obstacle factors of clinical pharmacy were analyzed to probe into the chance for clinical pharmacy in China brought out by New Medical Reform. RESULTS： The reimbursement mechanism reform of state hospitals, National Essential Drug System, medical insurance system, charge for pharmaceutical care system and the construction of primary hospitals and public health service provide development opportunities of clinical pharmacy. CONCLUSION： The development strategy of clinical pharmacy should be associated with New Medical Reform and relevant policy, laws and regulations of clinical pharmacy should be improved. Great importance should be attached to exploring the training system of clinical pharmacists and approaches of clinical pharmacy.

关 键 词：医改 临床药学 临床药师制 发展策略 

分 类 号：R95[医药卫生—药学]